약물 스크리닝 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 및 서비스별, 검체 유형별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Sample Type, By End User, By Region and Competition, 2020-2030F
상품코드:1881436
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 약물 스크리닝 시장은 2024년에 55억 6,000만 달러로 평가되었으며, 2030년까지 CAGR 5.3%로 성장하여 75억 8,000만 달러에 달할 것으로 예측됩니다.
세계 약물 스크리닝 시장은 생물학적 샘플에서 불법 약물, 규제 약물 및 그 대사 산물을 검출하도록 설계된 테스트 솔루션의 개발, 제조 및 유통으로 정의됩니다. 이 시장의 성장은 주로 전 세계 약물 남용의 증가와 직장 및 교통을 포함한 다양한 분야의 약물 검사에 대한 엄격한 규제 요건에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
55억 6,000만 달러
시장 규모 : 2030년
75억 8,000만 달러
CAGR : 2025-2030년
5.3%
가장 빠르게 성장하는 부문
소변 검체
최대 시장
북미
주요 시장 촉진요인
전 세계 약물 스크리닝 시장은 전 세계적으로 증가하는 약물 남용률에 큰 영향을 받고 있습니다. 불법 약물 사용이 계속 증가함에 따라 의료, 직장, 형사 사법 등 다양한 분야에서 효과적인 검사 솔루션에 대한 수요가 증가하고 있습니다.
주요 시장 과제
새로운 합성 약물과 디자이너 약물의 지속적인 출현은 세계 약물 스크리닝 시장의 성장에 큰 장벽이 되고 있습니다. 이러한 빠르게 진화하는 화합물은 기존의 검출 조사 방법을 자주 회피하기 때문에 스크리닝 제공자에게 끊임없는 분석 기술 혁신이 요구되고 있습니다.
주요 시장 동향
기술 발전은 검사 속도, 정확도, 검출 대상 물질의 범위를 향상시킴으로써 전 세계 약물 스크리닝 시장에 깊은 영향을 미치고 있습니다. 특히 검사의 무결성을 훼손하려는 시도가 증가함에 따라 분석 기술의 혁신은 매우 중요합니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 약물 스크리닝 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품 및 서비스별(약물 스크리닝 제품, 분석 기기, 신속 검사 기기, 구강액 검사 기기, 소모품, 약물 스크리닝 서비스)
검체 유형별(소변 검체, 호기 검체, 구강액 검체, 모발 검체, 기타 검체)
최종사용자별(약물 검사 연구소, 직장, 형사 사법·법집행 기관, 병원, 약물 치료 센터, 개인 사용자, 통증 관리 센터, 학교·컬리지)
지역별
기업별(2024)
시장 맵
제6장 북미의 약물 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 약물 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 약물 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 약물 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 약물 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 약물 스크리닝 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Quest Diagnostics Inc.
Heska Corporation
Thermo Fisher Scientific, Inc.
Alfa Scientific Designs, Inc.
OraSure Technologies, Inc.
F. Hoffmann-La Roche Ltd
MPD Inc.
Shimadzu Corporation
Lifeloc Technologies, Inc.
Dragerwerk AG & Co. KGaA
Premier Biotech, Inc.
Omega Laboratories, Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Drug Screening Market, valued at USD 5.56 Billion in 2024, is projected to experience a CAGR of 5.3% to reach USD 7.58 Billion by 2030. The global drug screening market is defined by the development, production, and distribution of testing solutions designed to detect illicit substances, controlled medications, and their metabolites in biological samples. This market's growth is primarily driven by the escalating global incidence of substance abuse and stringent regulatory mandates for drug testing across diverse sectors, including workplaces and transportation.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.56 Billion
Market Size 2030
USD 7.58 Billion
CAGR 2025-2030
5.3%
Fastest Growing Segment
Urine Samples
Largest Market
North America
Key Market Drivers
The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.
Key Market Challenges
The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.
Key Market Trends
Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.
Key Market Players
Quest Diagnostics Inc.
Heska Corporation
Thermo Fisher Scientific, Inc.
Alfa Scientific Designs, Inc.
OraSure Technologies, Inc.
F. Hoffmann-La Roche Ltd
MPD Inc.
Shimadzu Corporation
Lifeloc Technologies, Inc.
Dragerwerk AG & Co. KGaA
Premier Biotech, Inc.
Omega Laboratories, Inc.
Report Scope:
In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Drug Screening Market, By Product & Services:
Drug Screening Product
Analytical Instruments
Rapid Testing Devices
Oral Fluid Testing Devices
Consumables
Drug Screening Service
Drug Screening Market, By Sample Type:
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples
Drug Screening Market, By End User:
Drug Testing Laboratories
Workplaces
Criminal Justice and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools and Colleges
Drug Screening Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.
Available Customizations:
Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Drug Screening Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Services
6.2.2. By Sample Type
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Screening Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Services
6.3.1.2.2. By Sample Type
6.3.1.2.3. By End User
6.3.2. Canada Drug Screening Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Services
6.3.2.2.2. By Sample Type
6.3.2.2.3. By End User
6.3.3. Mexico Drug Screening Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Services
6.3.3.2.2. By Sample Type
6.3.3.2.3. By End User
7. Europe Drug Screening Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Services
7.2.2. By Sample Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Services
7.3.1.2.2. By Sample Type
7.3.1.2.3. By End User
7.3.2. France Drug Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Services
7.3.2.2.2. By Sample Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Drug Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Services
7.3.3.2.2. By Sample Type
7.3.3.2.3. By End User
7.3.4. Italy Drug Screening Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Services
7.3.4.2.2. By Sample Type
7.3.4.2.3. By End User
7.3.5. Spain Drug Screening Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Services
7.3.5.2.2. By Sample Type
7.3.5.2.3. By End User
8. Asia Pacific Drug Screening Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Services
8.2.2. By Sample Type
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Services
8.3.1.2.2. By Sample Type
8.3.1.2.3. By End User
8.3.2. India Drug Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Services
8.3.2.2.2. By Sample Type
8.3.2.2.3. By End User
8.3.3. Japan Drug Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Services
8.3.3.2.2. By Sample Type
8.3.3.2.3. By End User
8.3.4. South Korea Drug Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Services
8.3.4.2.2. By Sample Type
8.3.4.2.3. By End User
8.3.5. Australia Drug Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Services
8.3.5.2.2. By Sample Type
8.3.5.2.3. By End User
9. Middle East & Africa Drug Screening Market Outlook
